Story perspectives
Fosun and Leo Launch Game-Changing Cancer Treatment in China
11/7/2025
34 4
1 of 2
Fosun Enhances Cancer Care
- Fosun Pharmaceutical is collaborating with Leo Cancer Care to launch advanced particle therapy systems in mainland China, enhancing cancer treatment accessibility.
- This partnership aligns with Beijing's objective to improve healthcare services.
- Leo Cancer Care recently received FDA approval for its Marie medical facilities, which prioritize patient comfort and advanced technology.
- CEO Stephen Towe noted that the Marie system could cut treatment costs by 50% and is 20 times smaller than conventional radiation technology.
- This development represents a significant advancement in China's cancer care industry.
1 / 2
